WilliamF.SymmansMD

Pathology • Houston, TX

Blood Banking & Transfusion Medicine, Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Symmans is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Symmans' full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

NYU Grossman School of MedicineResidency, Immunopathology, 1993 - 1995
University of Texas M D Anderson Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
University of Auckland Faculty of Medicine and Health SciencesClass of 1986

Certifications & Licensure

TX State Medical License 2000 - 2025
NY State Medical License 1996 - 2003
PA State Medical License 1992 - 1996
American Board of Pathology Anatomic Pathology
American Board of Pathology Cytopathology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

1965 citations
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen
Annals of Oncology. 2015-02-01
419 citations
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adapt...
Rita Nanda, Minetta C. Liu, Christina Yau, Rebecca Shatsky, Lajos Pusztai
JAMA Oncology. 2020-05-01
108 citations
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
Denise M Wolf, Christina Yau, Julia Wulfkuhle, Lamorna Brown-Swigart, Rosa I Gallagher
Cancer Cell. 2022-06-13

Press Mentions

Residual Cancer Burden Predicts Outcomes for All Breast Cancer TypesFebruary 25th, 2020

Committees

Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present